February 1, 2019
Oncolys President Yasuo Urata Oncolys BioPharma plans to initiate a PII study of its oncolytic virus telomelysin in Japan in the second half of 2019 to obtain data for regulatory approval for an indication of esophageal cancer, President Yasuo Urata...read more